1.
BMJ Case Rep
; 14(5)2021 May 31.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34059544
RESUMEN
Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).